Helix Acquisition Corp, a Nasdaq-listed special purpose acquisition company and MoonLake Immunotherapeutics, a Swiss based clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases agreed on a business combination. At
Tags :Kevin MacCabe
The team includes partners Tino Gaberthüel (Corporate / M&A - pictured), Beat Kühni (Real Estate), Marcel Tranchet (Finance), Astrid Waser (Competition) and Pascal Hinny (Tax) as well as Eric Meier, Alex Wille, Xavier
Lenz & Staehelin acts as Swiss counsel to ARICOMA Group. The team includes Tino Gaberthüel (pictured) and Lukas Held (Corporate/M&A), Marcel Tranchet and Kevin MacCabe (Banking/Finance), Leo Rusterholz (IT) and Nicole Koch-Frey (